Wheelers Books
Refine By
Publication Date
Fiction / Non-Fiction
    Age
      Format
        Extended Format
        Show Large Print:
        Category
          Publication Country
            Latest Additions
            Language
              Price
              -

              Books by Board on Population Health and Public Health Practice

              Stock Availability: Sort by: View:

              Total 145 jump to: go ‹ previous12345...next ›
              Antivirals for Pandemic Influenza: Guidance on Developing a Distribution and Dispensing Program

              Antivirals for Pandemic Influenza: Guidance on Developing a Distribution and Dispensing Program (Trade Paperback / Paperback)

              By Institute of Medicine; Board on Population Health and Public Health Practice; Committee on Implementation of Antiviral Medication Strategies for an Influenza Pandemic

              • RRP: $49.99
              • $47.49
              • Save $2.50
              • Available At Publisher

              Calls for a national and public process of creating an ethical framework for antiviral use within the context of uncertainty and scarcity. This report identifies the lack of a science-based advisory body to guide decision making during the pandemic, including guidance on all dime...nsions of antiviral dispensing.
              Read more

              ISBN 9780309118668
              Released NZ 15 Jun 2008
              Publisher FOOTPRINT BOOKS
              Interest Age General Audience
              Availability
              Showing available at publisher; usually ships 7-14 working days
              View details for this title
              Public Health Effectiveness of the FDA 510(k) Clearance Process: Measuring Postmarket Performance and Other Select Topics: Workshop Report

              Public Health Effectiveness of the FDA 510(k) Clearance Process: Measuring Postmarket Performance and Other Select Topics: Workshop Report (Trade Paperback / Paperback)

              By Institute of Medicine; Board on Population Health and Public Health Practice; Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process; Edited by Wizemann, Theresa

              • RRP: $69.00
              • $65.55
              • Save $3.45
              • Available At Publisher

              The Food and Drug Administration (FDA) is responsible for ensuring that medical devices are safe and effective before they go on the market. Section 510(k) of the Federal Food, Drug, and Cosmetic Act requires a manufacturer of medical devices to notify FDA of its intent to market... a medical device at least 90 days in advance. That window of time allows FDA to evaluate whether the device is substantially equivalent to a product already legally on the market (called a predicate), in which case the device does not need to go through the premarket approval (PMA) process. As part of its assessment of the FDA's premarket clearance process for medical devices, the Institute of Medicine (IOM) held a workshop on July 28, 2010 to discuss how medical devices are monitored for safety after they are available to consumers. Its primary focus was on monitoring the safety of marketed medical devices, including FDA's postmarket surveillance activities, analysis of safety concerns that resulted in medical device recalls, and non-FDA sources of adverse-event information. Public Health Effectiveness of the FDA 501(K) Clearance Process summarizes the views of the workshop participants. --Publisher's description.
              Read more

              ISBN 9780309162067
              Released NZ 15 May 2011
              Publisher FOOTPRINT BOOKS
              Interest Age General Audience
              Availability
              Showing available at publisher; usually ships 7-14 working days
              View details for this title
              Clinical Preventive Services for Women: Closing the Gaps

              Clinical Preventive Services for Women: Closing the Gaps (Trade Paperback / Paperback)

              By Institute of Medicine; Board on Population Health and Public Health Practice; Committee on Preventive Services for Women

              • RRP: $95.00
              • $90.25
              • Save $4.75
              • Available At Publisher

              Women suffer disproportionate rates of chronic disease and disability from some conditions, and often have high out-of-pocket health care costs. The passage of the Patient Protection and Affordable Care Act of 2010 (ACA) provides the United States with an opportunity to reduce ex...isting health disparities by providing an unprecedented level of population health care coverage. The expansion of coverage to millions of uninsured Americans and the new standards for coverage of preventive services that are included in the ACA can potentially improve the health and well-being of individuals across the United States. Women in particular stand to benefit from these additional preventive health services. Clinical Preventive Services for Women reviews the preventive services that are important to women's health and well-being. It recommends that eight preventive health services for women be added to the services that health plans will cover at no cost. The recommendations are based on a review of existing guidelines and an assessment of the evidence on the effectiveness of different preventive services. The services include improved screening for cervical cancer, sexually transmitted infections, and gestational diabetes; a fuller range of contraceptive education, counseling, methods, and services; services for pregnant women; at least one well-woman preventive care visit annually; and screening and counseling for interpersonal and domestic violence, among others. Clinical Preventive Services for Women identifies critical gaps in preventive services for women as well as measures that will further ensure optimal health and well-being. It can serve as a comprehensive guide for federal government agencies, including the Department of Health and Human Services and the Center for Disease Control and Prevention; state and local government agencies; policy makers; health care professionals; caregivers, and researchers.
              Read more

              ISBN 9780309215381
              Released NZ 15 Oct 2011
              Publisher FOOTPRINT BOOKS
              Interest Age General Audience
              Availability
              Showing available at publisher; usually ships 7-14 working days
              View details for this title
              Medical Devices and the Public's Health: The FDA 510(k) Clearance Process at 35 Years

              Medical Devices and the Public's Health: The FDA 510(k) Clearance Process at 35 Years (Trade Paperback / Paperback)

              By Institute of Medicine; Board on Population Health and Public Health Practice; Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process

              • RRP: $104.00
              • $98.80
              • Save $5.20
              • Available At Publisher

              Medical devices that are deemed to have a moderate risk to patients generally cannot go on the market until they are cleared through the FDA 510(k) process. In recent years, individuals and organizations have expressed concern that the 510(k) process is neither making safe and ef...fective devices available to patients nor promoting innovation in the medical-device industry. Several high-profile mass-media reports and consumer-protection groups have profiled recognized or potential problems with medical devices cleared through the 510(k) clearance process. The medical-device industry and some patients have asserted that the process has become too burdensome and is delaying or stalling the entry of important new medical devices to the market. At the request of the FDA, the Institute of Medicine (IOM) examined the 510(k) process. Medical devices and the public's health examines the current 510(k) clearance process and whether it optimally protects patients and promotes innovation in support of public health. It also identifies legislative, regulatory, or administrative changes that will achieve the goals of the 510(k) clearance process. Medical devices and the public's health recommends that the U.S. Food and Drug Administration gather the information needed to develop a new regulatory framework to replace the 35-year-old 510(k) clearance process for medical devices. According to the report, the FDA's finite resources are best invested in developing an integrated premarket and postmarket regulatory framework --Publisher's description.
              Read more

              ISBN 9780309212427
              Released NZ 15 Oct 2011
              Publisher FOOTPRINT BOOKS
              Interest Age General Audience
              Availability
              Showing available at publisher; usually ships 7-14 working days
              View details for this title
              Ethical and Scientific Issues in Studying the Safety of Approved Drugs

              Ethical and Scientific Issues in Studying the Safety of Approved Drugs (Trade Paperback / Paperback)

              By Institute of Medicine; Board on Population Health and Public Health Practice; Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs

              • RRP: $89.00
              • $84.55
              • Save $4.45
              • Available At Publisher

              An estimated 48 percent of the population takes at least one prescription drug in a given month. Drugs provide great benefits to society by saving or improving lives. Many drugs are also associated with side effects or adverse events, some serious and some discovered only after t...he drug is on the market. The discovery of new adverse events in the postmarketing setting is part of the normal natural history of approved drugs, and timely identification and warning about drug risks are central to the mission of the Food and Drug Administration (FDA). Not all risks associated with a drug are known at the time of approval, because safety data are collected from studies that involve a relatively small number of human subjects during a relatively short period. Written in response to a request by the FDA, Ethical and Scientific Issues in Studying the Safety of Approved Drugs discusses ethical and informed consent issues in conducting studies in the postmarketing setting. It evaluates the strengths and weaknesses of various approaches to generate evidence about safety questions, and makes recommendations for appropriate followup studies and randomized clinical trials. The book provides guidance to the FDA on how it should factor in different kinds of evidence in its regulatory decisions. Ethical and Scientific Issues in Studying the Safety of Approved Drugs will be of interest to the pharmaceutical industry, patient advocates, researchers, and consumer groups.
              Read more

              ISBN 9780309218139
              Released NZ 15 Dec 2012
              Publisher FOOTPRINT BOOKS
              Interest Age 19+ years
              Availability
              Showing available at publisher; usually ships 7-14 working days
              View details for this title
              U.S. Health in International Perspective: Shorter Lives, Poorer Health

              U.S. Health in International Perspective: Shorter Lives, Poorer Health (Trade Paperback / Paperback)

              By Panel on Understanding Cross-National Health Differences Among High-Income Countries; on Population, Committee; Division of Behavioral and Social Sciences and Education; Research Council, National; Board on Population Health and Public Health Practice

              • RRP: $115.00
              • $109.25
              • Save $5.75
              • Available At Publisher

              The United States is among the wealthiest nations in the world, but it is far from the healthiest. Although life expectancy and survival rates in the United States have improved dramatically over the past century, Americans live shorter lives and experience more injuries and illn...esses than people in other high-income countries. The U.S. health disadvantage cannot be attributed solely to the adverse health status of racial or ethnic minorities or poor people: even highly advantaged Americans are in worse health than their counterparts in other, peer countries. In light of the new and growing evidence about the U.S. health disadvantage, the National Institutes of Health asked the National Research Council (NRC) and the Institute of Medicine (IOM) to convene a panel of experts to study the issue. The Panel on Understanding Cross-National Health Differences Among High-Income Countries examined whether the U.S. health disadvantage exists across the life span, considered potential explanations, and assessed the larger implications of the findings. U.S. Health in International Perspective presents detailed evidence on the issue, explores the possible explanations for the shorter and less healthy lives of Americans than those of people in comparable countries, and recommends actions by both government and nongovernment agencies and organizations to address the U.S. health disadvantage.
              Read more

              ISBN 9780309264143
              Released NZ 15 Apr 2013
              Publisher FOOTPRINT BOOKS
              Interest Age General Audience
              Availability
              Showing available at publisher; usually ships 7-14 working days
              View details for this title
              Demographic Changes, a View from California: Implications for Framing Health Disparities: Workshop Summary

              Demographic Changes, a View from California: Implications for Framing Health Disparities: Workshop Summary (Trade Paperback / Paperback)

              By Roundtable on the Promotion of Health Equity and the Elimination of Health Disparities; Board on Population Health and Public Health Practice; Institute of Medicine; Edited by Anderson, Karen M.

              • RRP: $37.99
              • $36.09
              • Save $1.90
              • Available At Publisher

              The IOM held a workshop on July 28, 2008, to examine strategies for discussing health disparities in ways that engage the public and motivate change. Speakers focused on health disparities in California, which continues to see dramatic demographic shifts. --Publisher's descriptio...n.
              Read more

              ISBN 9780309148863
              Released NZ 15 Jun 2010
              Publisher FOOTPRINT BOOKS
              Interest Age General Audience
              Availability
              Showing available at publisher; usually ships 7-14 working days
              View details for this title
              Traumatic Injury Research at NIOSH

              Traumatic Injury Research at NIOSH (Paperback)

              By Committee to Review the NIOSH Traumatic Injury Research Program; Board on Population Health and Public Health Practice; Institute of Medicine; Research Council, National

              • RRP: $79.00
              • $75.05
              • Save $3.95
              • Available At Publisher

              The occurrences of both injury and death that take place on the job are a significant public health problem in the United States, causing a substantial human and economic burden. Part of the series Reviews of Research Programs of the National Institute for Occupational Safety and... Health, this report addresses the subject.
              Read more

              ISBN 9780309125079
              Released NZ 15 Dec 2008
              Publisher FOOTPRINT BOOKS
              Interest Age General Audience
              Availability
              Showing available at publisher; usually ships 7-14 working days
              View details for this title
              Leading Health Indicators for Healthy People 2020: Letter Report

              Leading Health Indicators for Healthy People 2020: Letter Report (Trade Paperback / Paperback)

              By Committee on Leading Health Indicators for Healthy People 2020; Board on Population Health and Public Health Practice; Institute of Medicine

              • RRP: $33.99
              • $32.29
              • Save $1.70
              • Available At Publisher

              For the past three decades, the Department of Health and Human Services (HHS) has issued a national agenda aimed at improving the health of all Americans over each 10-year span. Under each of these Healthy People initiatives, HHS established health targets and monitored how well ...people were reaching them over time. In response to a request from the Department of Health and Human Services (HHS), the Institute of Medicine (IOM) established the Committee on Leading Health Indicators for Healthy People 2020 to develop and recommend 12 indicators and 24 objectives for consideration by HHS for guiding a national health agenda and for consideration for inclusion in Healthy People 2020. The work of the committee built upon the 1999 IOM report, Leading Health Indicators for Healthy People 2010, and on the work of the Committee on the State of the USA Health Indicators. Leading Health Indicators for Healthy People 2020 lays out the proposed agenda for the current decade, which will end in 2020 --Publisher's description.
              Read more

              ISBN 9780309186377
              Released NZ 15 Apr 2011
              Publisher FOOTPRINT BOOKS
              Interest Age General Audience
              Availability
              Showing available at publisher; usually ships 7-14 working days
              View details for this title
              The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies

              The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies (Trade Paperback / Paperback)

              By Committee on the Assessment of Studies of Health Outcomes Related to the Recommended Childhood Immunization Schedule; Board on Population Health and Public Health Practice; Institute of Medicine

              • RRP: $76.00
              • $72.20
              • Save $3.80
              • Available At Publisher

              Reviews scientific findings and stakeholders concerns related to the safety of the recommended childhood immunization schedule. This report identifies potential research approaches, methodologies and study designs that could inform this question, considering strengths, weaknesses... as well as ethical and financial feasibility of each approach.
              Read more

              ISBN 9780309267021
              Released NZ 15 Apr 2013
              Publisher FOOTPRINT BOOKS
              Interest Age General Audience
              Availability
              Showing available at publisher; usually ships 7-14 working days
              View details for this title
              Total 145 jump to: go ‹ previous12345...next ›